Theratechnologies (TH) Sets New 1-Year Low at $8.50

Theratechnologies Inc (TSE:TH) reached a new 52-week low during trading on Monday . The stock traded as low as C$8.50 and last traded at C$8.51, with a volume of 128226 shares changing hands. The stock had previously closed at C$8.81.

Several research firms have recently commented on TH. Royal Bank of Canada restated a “sector perform” rating and set a C$11.00 price objective on shares of Theratechnologies in a report on Tuesday, September 4th. Canaccord Genuity boosted their price objective on Theratechnologies from C$13.00 to C$14.50 in a report on Friday, July 6th. Finally, National Bank Financial restated an “outperform” rating and set a C$14.25 price objective on shares of Theratechnologies in a report on Wednesday, June 20th.

Theratechnologies (TSE:TH) last released its quarterly earnings data on Thursday, July 5th. The company reported C($0.03) EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of C($0.03). The firm had revenue of C$12.33 million during the quarter, compared to the consensus estimate of C$13.40 million. Theratechnologies had a negative return on equity of 38.09% and a negative net margin of 33.47%.

About Theratechnologies (TSE:TH)

Theratechnologies Inc, a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. The company's lead product is EGRIFTA, which increases the incidence or progression of diabetic retinopathy in diabetic HIV-infected patients with lipodystrophy and excess abdominal fat in the United States and Canada.

Further Reading: Why do companies issue stock splits?

Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply